MarkWide Research - Global Market Intelligence Platform
Report Details
Historical Year
2020-2024
Base Year
2025
Forecast Period
2026-2036
Published Date
May 2026
No. of Pages
201 Pages
Delivery Format
PDF + Excel
Home›Industries›Healthcare›Medical Imaging›India Magnetic Resonance Imaging Market

India Magnetic Resonance Imaging Market Size, Share, and Industry Trends Forecast 2026-2036

The India Magnetic Resonance Imaging Market valued at $1.4 Billion in 2026 is projected to expand to $3.22 Billion by 2035, advancing at a 9.70% CAGR over the analysis window. Government hospitals are expanding procurement of high-field systems under the PLI scheme for medical devices. Demand concentrates in Maharashtra, Karnataka, and Tamil Nadu where tertiary care networks are densifying.

India Magnetic Resonance Imaging Market Foresight

High-field superconducting MRI systems is collapsing the gap between diagnostic capability and clinical throughput in India's tier-one hospitals. Siemens Healthineers leverages its cryogen-free platform development to sustain installed-base loyalty across metropolitan referral networks. Wipro GE Healthcare anchors its position through backward integration into coil manufacturing and local service infrastructure. Philips India competes on digital workflow integration that reduces scan-to-report latency in high-volume public hospital settings.

Magnetic Resonance Imaging deploys superconducting magnets generating field strengths from 1.5 to 3.0 Tesla, using radiofrequency coils and gradient systems to produce tomographic images of soft tissue, organs, and the central nervous system without ionizing radiation. Closed MRI systems dominate current procurement budgets due to superior signal-to-noise ratios and faster acquisition protocols, while open MRI configurations address the fastest-growing segment among bariatric and claustrophobic patient populations. Superconducting technology leads the technology dimension by installed value, though permanent magnet systems retain relevance in smaller diagnostic centers where helium logistics and cryocooler maintenance constrain operational budgets.

CDSCO regulates device licensing and clinical safety standards for MRI systems sold in India, while BIS certification governs electromagnetic compatibility and electrical safety compliance for domestic manufacture and import. The PLI scheme for medical devices is reshaping capital equipment sourcing patterns by incentivizing local assembly of high-value imaging components. Stakeholders must monitor how state-level health mission budgets allocate between new system procurement versus refurbished equipment deployment as infrastructure gaps persist across secondary care tiers.

India Magnetic Resonance Imaging Market Size and Forecast

Market Dynamics

The PLI scheme for medical devices is restructuring capital allocation across India's imaging infrastructure, redirecting procurement flows toward locally assembled high-field systems while state health missions expand tertiary care networks in underserved districts.

Growth Catalysts

  • PLI scheme for medical devices:Production-linked incentives are accelerating domestic assembly of superconducting magnets and gradient coils, reducing import dependency for high-value components in Maharashtra and Karnataka.
  • Tertiary care densification:State-level health missions in Tamil Nadu are commissioning 3.0 Tesla systems for oncology and neurology referral networks, creating installed-base expansion in metropolitan hospital clusters.
  • Helium conservation protocols:Cryogen-free magnet technology is eliminating liquid helium logistics burdens, enabling deployment in district hospitals previously excluded by infrastructure constraints.

Market Restraints

  • Superconducting wire supply concentration:Niobium-titanium filament production concentrates among a limited set of specialty metallurgical suppliers, exposing OEMs to raw material allocation volatility.
  • CDSCO licensing timelines:Device registration protocols for imported MRI systems create extended approval cycles, compressing effective equipment depreciation periods for private diagnostic chains.
  • Permanent magnet substitution ceiling:Field strength limitations below 0.5 Tesla constrain diagnostic utility for advanced neurovascular and oncologic protocols, restricting addressable patient segments.

Strategic Opportunities

  • Open MRI configurations:Bariatric and claustrophobic patient populations in Kerala and Gujarat represent underpenetrated demand pools where non-cylindrical geometries command premium scheduling rates.
  • Artificial intelligence reconstruction:Deep learning-based scan acceleration is converging with compressed sensing protocols, enabling throughput doubling without gradient hardware upgrades.
  • Refurbished equipment channels:Secondary care tiers in Uttar Pradesh and Bihar are accessing certified pre-owned 1.5 Tesla systems through leasing structures unavailable in primary procurement.

Industry Challenges

  • Clinical application specialist scarcity:Radiologists trained in advanced neuroimaging protocols remain concentrated in six metropolitan clusters, constraining effective utilization of high-field installations in tier-two cities.
  • BIS electromagnetic compliance testing:Certification bottlenecks for locally manufactured radiofrequency coils delay product launches, compressing margin recovery windows for domestic component suppliers.

Report Scope

MarkWide Research
AttributesDetails
Report TitleIndia Magnetic Resonance Imaging Market
Market Size in 2026$1.4 Billion
Market Size in 2035$3.22 Billion
CAGR (2026 – 2036)9.7%
Historical Year2020-2024
Base Year2025
Forecast Period2026-2036
Segmentation
Product Type: Closed MRI, Open MRI, Extremity MRI, Functional MRI
End User: Hospitals, Diagnostic Centers, Research Institutions, Outpatient Clinics
Technology: Superconducting, Permanent Magnet, Open Magnet, Hybrid Systems
Application: Neurology, Oncology, Musculoskeletal, Cardiovascular
Companies CoveredCanon Medical Systems, Hitachi Medical Systems, Siemens Healthineers, United Imaging Healthcare, Fujifilm Holdings Corporation, Wipro GE Healthcare, GE Healthcare, Allengers Medical Systems, Philips India, Others

Get the full picture before you read further.

Download a free sample with table of contents, companies, segments, and methodology.

India Magnetic Resonance Imaging Market Shifts & Advancements

Digital workflow integration and magnet cooling innovations are compressing scan-to-diagnosis intervals while expanding addressable patient populations beyond traditional cylindrical system constraints.

Helium-free superconducting platforms are supplanting conventional liquid helium-cooled systems in India's metropolitan hospital procurement. CDSCO-registered installations in Delhi and Mumbai are adopting cryocooler-based magnet technology to eliminate helium supply chain vulnerabilities. This shift is enabling 24/7 operational continuity while reducing lifecycle service costs for high-volume public hospital networks.

BIS certification requirements for electromagnetic compatibility are tightening quality thresholds for imported gradient amplifiers and radiofrequency transmitters. Domestic coil manufacturers in Bangalore and Hyderabad are investing in anechoic chamber testing infrastructure to accelerate compliance timelines. Private diagnostic chains are responding by consolidating supplier relationships with vendors holding pre-certified component portfolios.

Service unbundling is fragmenting traditional OEM maintenance contracts across India's independent diagnostic laboratory segment. Third-party technical service providers in Chennai and Pune are capturing coil repair and cryocooler refurbishment work previously captive to manufacturer networks. This behavioral shift is most visible in Maharashtra, where diagnostic chains operate multi-vendor installed bases exceeding fifty systems.

India Magnetic Resonance Imaging Market Segmentation

India Magnetic Resonance Imaging Market Segment

MRI segmentation in India tracks divergent procurement patterns between tertiary care networks prioritizing throughput and secondary care facilities constrained by infrastructure limitations. Understanding these divides clarifies where equipment financing, service contracts, and technology upgrade cycles concentrate revenue.

Product Type:

Margin pools concentrate in high-field closed systems where service contracts and contrast agent protocols generate recurring revenue streams.

  • Closed MRI:Cylindrical superconducting systems with 1.5 to 3.0 Tesla field strengths deliver superior signal-to-noise ratios for neurovascular and oncologic protocols. Maharashtra's tertiary care networks are standardizing on 3.0 Tesla configurations for oncology referral hubs, locking in long-term service dependencies with OEMs.
  • Open MRI:Non-cylindrical magnet geometries accommodate bariatric patients and claustrophobic populations without sedation protocols. Kerala and Gujarat diagnostic chains are capturing premium scheduling rates for these configurations, addressing patient populations previously excluded from cylindrical systems.
  • Extremity MRI:Dedicated limb-scanning systems with compact footprints target orthopedic specialist practices in Bangalore and Chennai.
  • Functional MRI:Blood-oxygen-level-dependent imaging systems map neural activation patterns for pre-surgical planning in metropolitan neurology centers.

Closed MRI holds installed capacity. Open MRI is rotating up the share rankings.

End User:

Procurement authority distributes across public budget cycles, private capital deployment, and research grant funding with distinct contracting rhythms.

  • Hospitals:Government teaching hospitals under state health missions dominate 3.0 Tesla acquisitions through PLI-linked tenders. Tamil Nadu's tertiary network densification is channeling high-field systems into public oncology and neurology referral centers with 24/7 operational mandates.
  • Diagnostic Centers:Independent laboratory chains in Maharashtra operate multi-vendor installed bases exceeding fifty systems, driving third-party service unbundling for coil repair and cryocooler refurbishment.
  • Research Institutions:Academic medical centers in Delhi and Mumbai deploy functional MRI for clinical trial endpoints and neuroimaging research protocols.
  • Outpatient Clinics:Compact extremity systems and refurbished 1.5 Tesla platforms serve orthopedic and sports medicine practices in tier-two cities.

Hospitals command capital allocation. Diagnostic Centers are climbing the fastest on volume throughput metrics.

Technology:

Field strength and cooling architecture determine total cost of ownership across helium logistics, cryocooler maintenance, and gradient amplifier replacement cycles.

  • Superconducting:Niobium-titanium magnet systems operating at 1.5 to 3.0 Tesla with liquid helium or cryocooler cooling dominate metropolitan procurement. Cryogen-free platforms are eliminating helium supply vulnerabilities for Delhi and Mumbai installations seeking 24/7 continuity.
  • Permanent Magnet:Iron-core systems below 0.5 Tesla avoid cryogenic infrastructure but constrain diagnostic utility for advanced protocols. Smaller diagnostic centers in Uttar Pradesh and Bihar deploy these where helium logistics and service technician availability remain prohibitive.
  • Open Magnet:Permanent or resistive magnet configurations in non-cylindrical geometries address bariatric and claustrophobic patient access gaps.
  • Hybrid Systems:Combined PET-MRI platforms fuse metabolic and anatomical imaging for oncology staging in specialized referral centers.

Superconducting technology anchors installed value. Permanent Magnet configurations are gaining share fastest in secondary care expansion.

Application:

Clinical protocol complexity and reimbursement rates vary sharply across neurological, oncological, and cardiovascular imaging workflows.

  • Neurology:Advanced neurovascular protocols including diffusion tensor imaging and functional mapping require 3.0 Tesla field strengths and specialized radiologist training. Karnataka's referral networks are concentrating clinical application specialists in Bangalore for pre-surgical planning.
  • Oncology:Whole-body staging and treatment response monitoring drive high-field system utilization in Tamil Nadu's public hospital networks, where PLI-incentivized procurement is expanding 3.0 Tesla capacity.
  • Musculoskeletal:Extremity and spine imaging protocols support orthopedic surgery planning and sports medicine diagnostics.
  • Cardiovascular:Cardiac MRI for myocardial perfusion and viability assessment remains concentrated in metropolitan centers with dedicated technologist training programs.

Neurology commands premium protocol margins. Oncology is expanding most quickly on state health mission budget allocation.

India Magnetic Resonance Imaging Market Segmentation

Need this report tailored to your region?

Request specific countries, segments, or companies — tailored to your requirements.

Regional Outlook

Superconducting magnet assembly clusters in Maharashtra and Karnataka concentrate domestic manufacturing capacity under the PLI scheme for medical devices. State health missions in Tamil Nadu and Telangana are channeling procurement toward high-field systems for oncology networks. Sub-regional variation reflects divergent infrastructure maturity and tertiary care densification timelines.

Maharashtra

Mumbai and Pune host the densest concentration of 3.0 Tesla installations serving private diagnostic chains and public teaching hospitals. The state health mission channels PLI-linked tenders toward cryogen-free platforms eliminating helium logistics burdens. Siemens Healthineers and Wipro GE Healthcare maintain service infrastructure in Mumbai metropolitan clusters supporting multi-vendor installed bases.

Karnataka

Bangalore anchors neuroimaging referral networks requiring advanced diffusion tensor and functional MRI protocols. CDSCO-registered installations in the city concentrate clinical application specialists for pre-surgical planning. The state's medical technology corridor is attracting gradient coil and radiofrequency component manufacturers seeking BIS certification proximity.

Tamil Nadu

Chennai's tertiary care densification is deploying PLI-incentivized 3.0 Tesla systems across public oncology and neurology centers. State health mission budgets prioritize 24/7 operational mandates for high-volume screening programs. Independent diagnostic laboratories in Coimbatore are capturing third-party service contracts for cryocooler refurbishment.

Telangana

Hyderabad's diagnostic center expansion is accessing refurbished 1.5 Tesla systems through leasing structures unavailable in primary procurement channels. The state's medical device park is incubating domestic coil manufacturers investing in anechoic chamber testing for BIS electromagnetic compliance. Outpatient clinics in tier-two cities are deploying compact extremity systems for orthopedic practices.

Delhi-NCR

Government teaching hospitals in Delhi are standardizing on cryogen-free superconducting platforms to ensure operational continuity amid helium supply constraints. CDSCO licensing timelines for imported systems create extended approval cycles compressing effective depreciation periods. Private diagnostic chains in Gurgaon and Noida are consolidating supplier relationships with vendors holding pre-certified component portfolios.

India Magnetic Resonance Imaging Market Competitive Landscape

Concentration sits with multinational imaging OEMs possessing captive cryogen-free technology and established service networks. The vendor structure tiers between premium-tier superconducting system suppliers and mid-tier permanent magnet fabricators addressing secondary care constraints. Three archetypes dominate: integrated diagnostic platform providers, component-specialized domestic assemblers, and refurbished equipment channel operators. Competitive positioning hardens through backward integration into coil manufacturing and local service infrastructure deployment.

Within the integrated platform tier, Siemens Healthineers, Wipro GE Healthcare, and Philips India represent the dominant multinational presence anchoring metropolitan procurement flows. These entities exemplify archetypes spanning cryogen-free magnet development, digital workflow integration, and multi-vendor service unbundling. Canon Medical Systems and Hitachi Medical Systems occupy positions in specialized configurations addressing bariatric and extremity imaging segments. United Imaging Healthcare and Fujifilm Holdings Corporation represent newer entrants seeking traction through pricing differentiation in secondary care expansion markets.

Leading Market Players
Canon Medical Systems
Hitachi Medical Systems
Siemens Healthineers
United Imaging Healthcare
Fujifilm Holdings Corporation
Wipro GE Healthcare
GE Healthcare
Allengers Medical Systems
Philips India
Others
Please Note: The list provided is preliminary and subject to refinement. Our final study will profile 15–20 companies, and we are happy to customize the selection to align with your specific needs.

Supply & Pricing Matrix

Long-term service contracts with embedded cryocooler maintenance clauses lock in both helium-free magnet access and predictable lifecycle costs for Maharashtra's public hospital networks under PLI-linked procurement. This contract structure insulates buyers from spot-market volatility in niobium-titanium filament pricing while committing OEMs to multi-year gradient coil replacement schedules.

Pricing Analysis

CDSCO licensing timelines dictate the pricing tier structure across imported versus domestically assembled MRI systems. Three-tier pricing structure across premium, standard, and economy levels separates cryogen-free 3.0 Tesla platforms from conventional helium-cooled 1.5 Tesla configurations and refurbished permanent magnet systems. Cost compression in the economy tier is intensifying because secondary care facilities in Uttar Pradesh and Bihar are accessing certified pre-owned equipment through leasing structures. Government teaching hospitals under state health missions exhibit lowest price sensitivity due to PLI subsidy absorption, while independent diagnostic chains in tier-two cities face acute margin pressure from multi-vendor service unbundling.

Supply Chain Analysis

Container availability constraints on Asia-Europe trade lanes are extending lead times for gradient amplifiers and radiofrequency transmitters destined for CDSCO-registered installations in Delhi and Mumbai. Niobium-titanium superconducting wire production concentrates in Japan, Germany, and the United States, while radiofrequency coil fabrication draws from China, South Korea, and domestic assembly clusters in Bangalore and Hyderabad. Single-source vulnerability in helium recovery infrastructure exposes cryogen-cooled system operators to supply disruption. Distribution runs through OEM-direct channels for metropolitan tertiary care networks and third-party service providers for independent diagnostic chains with multi-vendor installed bases.

India Magnetic Resonance Imaging Market SWOT Analysis

Get the full picture before you read further.

Download a free sample with table of contents, companies, segments, and methodology.

Analyst Recommendations

India's MRI market is recovering from pandemic-era procurement freezes as state health mission budgets normalize and PLI scheme disbursements accelerate domestic assembly capacity. This cyclical recovery is anchored in tertiary care densification timelines across Tamil Nadu, Karnataka, and Maharashtra.

For Market Incumbents: Compound installed-base loyalty by backward integration into coil manufacturing and captive cryocooler refurbishment infrastructure in Chennai and Pune. Extend service contract durations to preempt third-party unbundling threats from independent technical providers. Prioritize BIS electromagnetic compliance pre-certification for gradient amplifiers to compress registration timelines for CDSCO device licensing.

For New Entrants and Emerging Players: CDSCO fast-track registration for cryogen-free magnet platforms opens access to government tender pipelines previously locked by established OEM service networks. Target refurbished 1.5 Tesla system leasing in Telangana and Bihar where secondary care infrastructure gaps persist. Deploy direct-to-hospital financing partnerships bypassing traditional distributor markups in tier-two city clusters.

For Investors and Strategic Acquirers: Domestic coil manufacturers with anechoic chamber testing infrastructure and pre-certified BIS component portfolios represent acquisition targets with embedded regulatory moats. Long-term viability hinges on PLI scheme renewal beyond current disbursement windows and state health mission budget persistence. Monitor CDSCO registration queue lengths for imported systems as an inflection indicator for domestic assembly preference shifts.

Strategic Initiative Industry Significance
Helium-Free Magnet Platform Deployment Eliminates liquid helium logistics burdens for 24/7 public hospital operations in Delhi and Mumbai.
CDSCO Fast-Track Registration Investment Compresses approval cycles for cryogen-free systems competing against established installed bases.
Backward Integration into Coil Manufacturing Captures margin pools from radiofrequency component supply to multi-vendor diagnostic chains.
Third-Party Service Infrastructure Buildout Fragments traditional OEM maintenance contracts across Maharashtra's independent laboratory segment.
Refurbished Equipment Leasing Programs Unlocks secondary care access in Uttar Pradesh and Bihar through non-traditional procurement channels.

Research Methodology

Two parallel data streams informed the analysis: structured primary interviews with hospital biomedical engineers, GPO contracts managers, CDSCO regulatory affairs leads, and diagnostic chain procurement heads; and secondary validation against hospital procurement databases, PLI scheme disbursement records, BIS certification registries, and GPO contract repositories. Bottom-up triangulation across state health mission budget allocations and top-down reconciliation with OEM revenue disclosures anchored volume estimates.

Across the analysis window, the forecasting framework modeled demand by field strength tier, cooling architecture, end-user category, and regional infrastructure maturity. CAGRs were derived from equipment financing flow analysis and replacement cycle assumptions for superconducting versus permanent magnet systems. Forecast inputs incorporated PLI incentive utilization rates and tertiary care densification timelines by state.

Decision-makers should treat outputs as directional under assumptions of sustained PLI scheme funding and stable state health mission capital allocations; material deviation would warrant model refresh. Specific risk factors include CDSCO registration timeline extensions, niobium-titanium supply allocation volatility, and radiologist training pipeline constraints affecting effective utilization rates. Outcomes outside this envelope would require model recalibration.

Need Custom Data?

Can't find what you're looking for? Our analysts can build a custom report tailored to your exact requirements.

1,000+

Global Clients

150+

Countries Covered

65,000+

Reports Available

Frequently Asked Questions

Why Work With MWR

Trusted by 1,000+ businesses across 150+ countries for high-stakes market decisions.

Ready to access intelligence that moves business?

Browse Reports →

Trusted by Global Leaders

From Fortune-level organizations to global SMEs, we provide intelligence for high-stakes decisions.

Multi-Language Support

Research available in French, German, Spanish, Chinese, and more.

ISO & IAF Certified

Globally aligned quality standards ensuring methodological discipline and data integrity.

Competitive Relevance

Free inclusion of 3–4 additional companies of your choice in every report.

Customized Insights

Tailored intelligence for market entry, niche expansion, or competitive benchmarking.

Post-Sale Assistance

Dedicated coordination to help interpret findings and address queries post-delivery.

Cutting-Edge Methods

Structured data collection, advanced analytics, and expert validation for reliable forecasts.

Value for Investment

Credible, structured intelligence at a cost that makes strategic sense.

What Our Clients Say

"

My team needed the real numbers on AI spending for our Reinvention Services work. MarkWide delivered. No fluff, just a clear look at where the money is actually going. It saved us about three weeks of guesswork.

Accenture

"

We recently leaned on MarkWide Research for a deep dive into the evolving snacking habits within Southeast Asia. Their report on the premium biscuit segment was exceptionally detailed, providing us with the specific consumer sentiment data we needed to refine our regional flavor strategy. It wasn't just a data dump; the cultural nuances they captured helped us avoid several localization pitfalls.

Mondelez

Director of Global Consumer Insights

"

For a recent engagement in the automotive sector, we needed rigorous, independent verification of EV battery recycling capacities. MWR delivered a report that made our work easier. Their ability to segment the competitive landscape by chemical composition and regional throughput was exactly the kind of 'hard-to-find' intel that our team was looking for.

BCG

"

We were looking for a report on Xcelerator ecosystem's potential and got in touch with MarkWide's team through one of my old colleagues who worked with them in the past. Their research team was incredibly polite and were always available for us which was important for my team as this was a custom project. Their methodology for tracking industrial IoT adoption gave our R&D heads the clarity needed to prioritize our next-gen sensor development.

Siemens

Head of Industrial Digitalization

"

During a recent M&A project, we needed a fast, reliable breakdown of the Fintech landscape in Southeast Asia. MarkWide came through with a report that was actually readable and focused on the metrics that matter. It saved my team a good week of primary research, which, given our timelines, was a massive win.

KPMG

Advisory Partner

"

We tapped MarkWide Research for a deep dive into the ESG reporting software market. At Deloitte, our clients expect us to have the most current insights, and this report didn't disappoint. It provided a breakdown of the competitive field that was far more detailed than what we were expecting.

Deloitte

Lead Consultant, Sustainability Services

"

For our semiconductor division at Samsung, the supply chain forecast from MarkWide was incredibly useful. It provided a realistic outlook on raw material availability that helped us refine our production timelines. No fluff, just the data we needed to make a tough call.

Samsung

"

The value for our organization comes from three things: depth of research, specificity of segments and being easy to work with. As important as the first two are, the third can't be underestimated. MarkWide Research, maybe more than any other research vendor, wants to know what is top of mind for our team and what big questions we are grappling to answer. Their customer first approach and high value engagement model have given us great analysis and excellent value for money.

3M

"

I can share that it was a positive experience wherein MarkWide Research demonstrated flexibility to adapt to our needs and delivered an excellent report that fits all our requirements. Personally, I liked the timely follow up by the team and we will definitively reach out in case more research support is required.

VITO

Buy Now